Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
You can purchase shares of Leap Therapeutics (NASDAQ:LPTX) through any online brokerage.
Other companies in Leap Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE), Tonix Pharmaceuticals (NASDAQ:TNXP) and Lineage Cell Therapeutics (AMEX:LCTX).
Leap Therapeutics has a consensus price target of $10.40.
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $3.07 last updated December 20, 2024 at 6:00 PM EST.
There are no upcoming dividends for Leap Therapeutics.
Leap Therapeutics’s Q4 earnings are confirmed for Monday, March 17, 2025.
There is no upcoming split for Leap Therapeutics.
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.